Skip to Content

WPI 3629 (Hydromorphone Hydrochloride Extended-Release 8 mg)

Pill with imprint WPI 3629 is Brown, Round and has been identified as Hydromorphone Hydrochloride Extended-Release 8 mg. It is supplied by Watson Laboratories, Inc..

Hydromorphone is used in the treatment of chronic pain; cough; pain; anesthetic adjunct and belongs to the drug class narcotic analgesics. Risk cannot be ruled out during pregnancy. Hydromorphone 8 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).

Images for WPI 3629

Hydromorphone hydrochloride extended-release 8 mg WPI 3629

Hydromorphone Hydrochloride Extended-Release

Imprint:
WPI 3629
Strength:
8 mg
Color:
Brown
Shape:
Round
Availability:
Prescription only
Drug Class:
Narcotic analgesics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
2 - High potential for abuse
Labeler / Supplier:
Watson Laboratories, Inc.
National Drug Code (NDC):
00591-3629

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide